It has also been found that AP1G1 was highly expressed in several cancers and it was diminished in colon cancer tissues and cell lines, and silencing AP1G1 restored the role of HCP5 to slow down colon cancer progression [16]. This evidence concerns the gene AP1G1 and malignant colon neoplasm.